483
Georgia Eye Bank, Inc.FDA 483 - Georgia Eye Bank, Inc. - April 30, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Georgia Eye Bank, Inc. in Atlanta, GA, revealed a significant deficiency in its quality program. The firm failed to investigate deviations related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) and did not evaluate temperature alarms in its processing rooms. This indicates a lack of adherence to current good tissue practice (CGTP) requirements.
Open in Dashboard
ID · 5cd7c607-1e47-422d-b6ea-cc070ee6875a